Making cure when everyone else makes a treatment means that you can undercut everyone and eat their lunch so incentives are there

part of the problem is that developing treatments is easier and can rely on more conservative, safer assumptions while cures require more early stage risky research

besides chronic diseases that do have cures aren't considered chronic anymore. the rest are problems with insurance that doesn't want to cover single expensive cure over cheaper but recurrent treatment that might add up to more